Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

TxA2 antagonists/TxA2 synthase inhibitors from Fujisawa

July 12, 1996

Xenova reports on PAI inhibitor R&D

July 5, 1996

Role of adhesion molecules in hemostasis

July 5, 1996

Excellent antiplatelet activity seen with (R)-(-)-NSP-307

July 5, 1996

FK-633 in phase II trials

June 28, 1996

Fibrinogen antagonists in Terumo's pipeline

June 28, 1996

Neutralase covered under Japanese patent

June 28, 1996

Texas Biotechnology and Synthelabo enter new argatroban collaboration

June 28, 1996

BCH-2763: BioChem Therapeutic's novel thrombin inhibitor

June 28, 1996

Nippon Mining reports on HV1C3

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...